GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » Gross Margin %

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Gross Margin % : 53.81% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Harbin Gloria Pharmaceuticals Co's Gross Profit for the three months ended in Mar. 2024 was ¥319 Mil. Harbin Gloria Pharmaceuticals Co's Revenue for the three months ended in Mar. 2024 was ¥593 Mil. Therefore, Harbin Gloria Pharmaceuticals Co's Gross Margin % for the quarter that ended in Mar. 2024 was 53.81%.

Warning Sign:

Harbin Gloria Pharmaceuticals Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -5.5%.


The historical rank and industry rank for Harbin Gloria Pharmaceuticals Co's Gross Margin % or its related term are showing as below:

SZSE:002437' s Gross Margin % Range Over the Past 10 Years
Min: 56.92   Med: 66.89   Max: 74.55
Current: 57.48


During the past 13 years, the highest Gross Margin % of Harbin Gloria Pharmaceuticals Co was 74.55%. The lowest was 56.92%. And the median was 66.89%.

SZSE:002437's Gross Margin % is ranked better than
68.86% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.51 vs SZSE:002437: 57.48

Harbin Gloria Pharmaceuticals Co had a gross margin of 53.81% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Harbin Gloria Pharmaceuticals Co was -5.50% per year.


Harbin Gloria Pharmaceuticals Co Gross Margin % Historical Data

The historical data trend for Harbin Gloria Pharmaceuticals Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Gloria Pharmaceuticals Co Gross Margin % Chart

Harbin Gloria Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.35 74.04 73.62 56.92 58.39

Harbin Gloria Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.80 98.24 77.72 -13.93 53.81

Competitive Comparison of Harbin Gloria Pharmaceuticals Co's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Gloria Pharmaceuticals Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Gloria Pharmaceuticals Co's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Gloria Pharmaceuticals Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Harbin Gloria Pharmaceuticals Co's Gross Margin % falls into.



Harbin Gloria Pharmaceuticals Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Harbin Gloria Pharmaceuticals Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=1533.3 / 2626.039
=(Revenue - Cost of Goods Sold) / Revenue
=(2626.039 - 1092.711) / 2626.039
=58.39 %

Harbin Gloria Pharmaceuticals Co's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=319.2 / 593.133
=(Revenue - Cost of Goods Sold) / Revenue
=(593.133 - 273.973) / 593.133
=53.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Harbin Gloria Pharmaceuticals Co  (SZSE:002437) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Harbin Gloria Pharmaceuticals Co had a gross margin of 53.81% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Harbin Gloria Pharmaceuticals Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Gloria Pharmaceuticals Co (SZSE:002437) Business Description

Traded in Other Exchanges
N/A
Address
Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025
Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.
Executives
Guo Yun Pei Independent director
Wang Yu Supervisors
Yang Hong Bing Director
Diao Xiu Qiang Directors, executives
Liu Yue Yin Securities Affairs Representative
Guo Lei Feng Directors, Directors, and Executives
Li Jun Ling Director
Yang Hai Feng Executives
Zhang Su Mei Supervisors
Zhu Ji Man Director

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Headlines

No Headlines